Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Shaping the Future of Mental Health

We hope you enjoy this slid­edeck sup­port­ing two great ses­sions held dur­ing the 2017 Sharp­Brains Vir­tu­al Sum­mit: Brain Health & Enhance­ment in the Dig­i­tal Age (Decem­ber 5–7th, 2017). Read the rest of this entry »

Time to rethink Mental Health, especially anxiety disorders and depression

The glob­al men­tal health cri­sis could cost the world $16 tril­lion by 2030. With men­tal dis­or­ders on the rise in every coun­try in the world, nowhere is immune.

Poor men­tal health stops employ­ees from reach­ing their full poten­tial and forces them to take more sick days, stunt­ing pro­duc­tiv­i­ty and eco­nom­ic growth. This is also a chal­lenge with soci­ety-wide ram­i­fi­ca­tions. Lone­li­ness and iso­la­tion affect many of the most vul­ner­a­ble among us. Peo­ple with seri­ous con­di­tions such as schiz­o­phre­nia or bipo­lar dis­or­der are espe­cial­ly like­ly to be mar­gin­alised by their com­mu­ni­ties. Those with the most severe con­di­tions pay with their lives, dying pre­ma­ture­ly – as much as two decades before their time.

For­tu­nate­ly, com­ing into Davos this year we are rid­ing a sea change in how the world approach­es men­tal health.

–> Keep read­ing Why this is the year we must take action on men­tal health over at the World Eco­nom­ic Forum blog.

Article in context:

Update: Only 5% of US children ages 8–11 follow guidelines recommended for brain development

___

Dear read­er,

Time for Sharp­Brains month­ly e-newslet­ter, dis­cussing the lat­est inno­va­tions for brain health and men­tal health, and open­ing in this occa­sion with an impor­tant wake-up call.

New research:

New tools:

 

Hap­py Hal­loween and have a great month of Novem­ber,

 

The Sharp­Brains Team

FDA clears MindMaze GO neurorehabilitation platform, easing access to continued outpatient therapy

___

Mind­Maze Con­sol­i­dates First-ever FDA Approval for Inpa­tient and Out­pa­tient Neu­rore­ha­bil­i­ta­tion Ther­a­py (press release):

Mind­Maze, a leader in brain­tech, has today announced that it has obtained FDA clear­ance to launch its portable neu­rore­ha­bil­i­ta­tion prod­uct, Mind­Mo­tion™ GO, in the Unit­ed States. Togeth­er with Mind­Mo­tion PRO (which received FDA clear­ance in 2017), Mind­Mo­tion GO is the next offer­ing in the company’s con­tin­u­um of care, pro­vid­ing gam­i­fied neu­rore­ha­bil­i­ta­tion ther­a­py. Read the rest of this entry »

Why the Future of Brain Enhancement and Mental Health is Digital and Pervasive

___

It was a great plea­sure to share lat­est data and insights with a fan­tas­tic com­mu­ni­ty of researchers, engi­neers, inno­va­tors and investors, host­ed by the Impe­r­i­al Col­lege Cen­tre for Neu­rotech­nol­o­gy in Lon­don. Hope you enjoy the slides!

Talk descrip­tion: As seen in patent and invest­ment trends, research find­ings and consumer/patient behav­iors, Men­tal Health and Brain Enhance­ment are rapid­ly evolv­ing in trans­for­ma­tion­al ways which some call “empow­er­ing” and some “con­tro­ver­sial.” Alvaro Fer­nan­dez, Edi­tor-in-Chief of inde­pen­dent mar­ket research firm Sharp­Brains, will present and dis­cuss the lat­est mar­ket data and fore­casts on how dig­i­tal plat­forms are poised to rev­o­lu­tion­ize brain & men­tal health diag­nos­tics, mon­i­tor­ing, ther­a­pies and enhance­ment.

More pub­lic events Here and upcom­ing vir­tu­al con­fer­ence Here.

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters and more, SharpBrains is an independent market research firm tracking health and performance applications of brain science.

Follow us and Engage via…

twitter_logo_header
RSS Feed

Search for anything brain-related in our article archives

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.